485 / 923
Conclusions
Excellent long term results of permanent seed implants for low-risk and
intermediate-risk patients
High-risk patients may benefit from combined EBRT and seed treatment
Toxicity is low and acceptable
No decrease in long term QoL
Quality assurance very important
Anti-androgen therapy does not seem to influence outcome in seed
monotherapy